Epidemiology of Macrovascular Disease and Hypertension in Diabetes Mellitus
Epidemiology of Macrovascular Disease and Hypertension in Diabetes Mellitus
复制标题
糖尿病大血管疾病和高血压的流行病学
DOI:
--
复制
发表时间:
2003
期刊:
影响因子:
--
通讯作者:
D. Jakovljević
中科院分区:
文献类型:
--
作者:
J. Tuomilehto;D. Rastenytė;Q. Qiao;D. Jakovljević
Macrovascular diseases—atherosclerosis, coronary heart disease, cerebrovascular disease or stroke, and peripheral vascular disease—are major causes of morbidity, mortality, and severe disability among diabetic persons. Hypertension is a major contributor to macrovascular disease in diabetic patients. Although late macrovascular complications are common in both type 1 diabetes mellitus and type 2 diabetes mellitus, a somewhat different etiology has been suggested for these two types of diabetes. A number of studies have attempted to answer the basic questions of the epidemiology of hypertension and macrovascular disease in diabetes: (1) What is the occurrence of these disorders in diabetic patients? (2) Are they more common in diabetic patients compared with the general population? (3) Are the risk factors for these disorders the same in diabetic patients as in the general population? (4) Is asymptomatic hyperglycemia an independent risk factor for macrovascular disease? Our ability to diagnose different late complications of diabetes vary. For instance, we may be able to detect retinopathy and increased urinary albumin excretion earlier than clinical macrovascular disease (for which usually 75% stenosis is needed for clinical effects). In addition, the occurrence of macrovascular disease shows a very large geographical variation in the general population. This may also be reflected in between-population variation in the prevalence of hypertension and macrovascular complications of diabetes. Therefore, the risk of macrovascular disease in diabetic patients must always be interpreted in relation to the risk in the background population. The risk can be expressed in different ways: (1) absolute risk, i.e. as the excess number of cases or excess in the frequency of these complications between diabetic and nondiabetic subjects; (2) relative risk (rate ratio), i.e. ratio of the frequency between diabetic and nondiabetic subjects; (3) population attributable risk, i.e. the proportion of cases of these complications that can be attributed to diabetes, and thereby could possibly be prevented by measures targeted to primary and secondary prevention of diabetes.
Keywords:
hypertension;
proteinuria;
microalbuminuria;
blood pressure;
hyperinsulinemia;
insulin resistance;
hyperglycemia;
diurnal;
atherosclerosis;
coronary heart disease;
CHD;
mortality;
stroke;
cerebrovascular disease;
CVD
登录
查看更多内容
DOI:
10.1016/s1062-1458(01)00374-9
发表时间:
2001-05
期刊:
JAMA
影响因子:
--
作者:
P. Ridker;M. Stampfer;N. Rifai
通讯作者:
P. Ridker;M. Stampfer;N. Rifai
影响因子:
37.8
作者:
Haffner, SM;Mykkänen, L;Stern, MP
通讯作者:
Stern, MP
影响因子:
6.5
作者:
F. Karpe;S. Boquist;Rong Tang;Gene M. Bond;U. Faire;Anders Hamsten
通讯作者:
F. Karpe;S. Boquist;Rong Tang;Gene M. Bond;U. Faire;Anders Hamsten
影响因子:
5.1
作者:
Tuomilehto,J;Zimmet,P;Kankaanpää,J;Wolf,E;Hunt,D;King,H;Ram,P
通讯作者:
Ram,P
影响因子:
15.9
作者:
ANDERSON, EA;HOFFMAN, RP;MARK, AL
通讯作者:
MARK, AL